🇺🇸 FDA
Pipeline program

SSS17

SYSS-SSS17-UND-I-02

Phase 1 small_molecule active

Quick answer

SSS17 for Anemia in Chronic Kidney Diseases is a Phase 1 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Anemia in Chronic Kidney Diseases
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials